Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2012
12/27/2012US20120329076 Antibodies to Non-Functional Oligomeric P2X7 Receptors
12/27/2012US20120329073 Method of detecting pork in processed food and detection kit therefor
12/27/2012US20120329069 Methods for antibody engineering
12/27/2012US20120329063 Novel means for the diagnosis and therapy of ctcl
12/27/2012US20120329062 Rapid, Sensitive and Quantitative Methods for Tissue and Cell-Based Proteomics Via Consecutive Additional Quantifiable Extenders
12/27/2012US20120329057 Beef-specific age determination marker containing the p21 protein
12/27/2012US20120329055 Use of alpha1g subunit of t-type calcium channel as diagnostic marker for pregnancy in cattle
12/27/2012US20120329052 Identification of a dna variant associated with adult type hypolactasia
12/27/2012US20120328637 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
12/27/2012US20120328632 Inhibition of leukocyte adhesion
12/27/2012US20120328628 Antibodies to conformationally trapped proteins
12/27/2012US20120328625 Targeted binding agents directed to sonic hedgehog homolog and uses thereof
12/27/2012US20120328624 Anti-dll3 antibody
12/27/2012US20120328623 ANTI-erbB3 ANTIBODY
12/27/2012US20120328622 Novel compounds
12/27/2012US20120328620 Epidermalgrowth factor receptor mutations
12/27/2012US20120328619 Trispecific Therapeutics Against Acute Myeloid Leukaemia
12/27/2012US20120328616 Human antigen binding proteins that bind to a complex comprising beta-klotho and an fgf receptor
12/27/2012US20120328614 Immunoglobulin Formulation and Method of Preparation Thereof
12/27/2012US20120328613 Humanized anti-factor d antibodies and uses thereof
12/27/2012US20120328612 Anti-flt3 antibodies and methods of using the same
12/27/2012US20120328608 Methods of treating cancer using notch antagonists
12/27/2012US20120328599 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
12/27/2012US20120328562 Method and system to remove soluble tnfr1, tnfr2 and il2 in patients
12/27/2012US20120328559 Compositions and Methods for Treating Inflammatory Lung Disease
12/27/2012US20120328528 Monoclonal antibody against necrosis marker prdx4 and use thereof
12/27/2012US20120328524 Anti-gd2 antibodies and methods and uses related thereto
12/27/2012US20120328513 Compositions against cancer antigen liv-1 and uses thereof
12/27/2012US20120328511 Novel Antigen Binding Proteins
12/27/2012DE102004031579B4 Peptide zur Inhibition der Interaktion von Proteinkinase A und Proteinkinase A-Ankerproteinen, diese umfassendes Nukleinsäuremolekül, Vektor, Wirtszelle, gegen diese gerichtetes Erkennungsmolekül, diese enthaltende pharmazeutische Zusammensetzung, diese enthaltender Kit und deren Verwendung Peptides to inhibit the interaction of protein kinase A and protein kinase A anchoring proteins, these nucleic acid molecule comprising, vector, host cell recognition molecule directed against these, these containing pharmaceutical composition containing them and their use kit
12/27/2012CA2840461A1 Anti-erbb3 antibody
12/27/2012CA2840127A1 Fc variants with reduced effector functions
12/27/2012CA2840113A1 An il-15 and il-15r.alpha. sushi domain based immunocytokines
12/27/2012CA2839917A1 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
12/27/2012CA2839834A1 Binding domains directed against gpcr:g protein complexes and uses derived thereof
12/27/2012CA2839779A1 Serum albumin binding proteins
12/27/2012CA2839563A1 Anti-alpha synuclein binding molecules
12/27/2012CA2839508A1 Anti-axl antibodies and uses thereof
12/27/2012CA2839480A1 Anti-axl antibodies and uses thereof
12/27/2012CA2838484A1 Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer
12/27/2012CA2837998A1 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
12/27/2012CA2835772A1 Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes
12/26/2012EP2537933A1 An IL-15 and IL-15Ralpha sushi domain based immunocytokines
12/26/2012EP2537931A1 Antiviral agent, abzyme, primer set, method for producing polynucleotide, and method for producing polypeptide
12/26/2012EP2537864A1 Fc variants with reduced effector functions
12/26/2012EP2536836A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536835A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536834A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536833A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536764A1 Anti-cd28 humanized antibodies
12/26/2012EP2536763A1 Activatable constructs
12/26/2012EP2536762A2 INTEGRIN alpha V beta 8 NEUTRALIZING ANTIBODY
12/26/2012EP2536761A2 Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof
12/26/2012EP2536760A2 Novel phosphorylation of cardiac troponin i as a monitor for cardiac injury
12/26/2012EP2536759A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
12/26/2012EP2536758A1 Anti-hpv e7 antibodies
12/26/2012EP2536433A2 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases
12/26/2012EP2536432A1 Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
12/26/2012EP2536430A1 Compositions and methods for targeting type 1 interferon producing cells
12/26/2012EP2250196B1 Engineered constant domain molecule of an antibody
12/26/2012CN102844332A Antibodies with ph dependent antigen binding
12/26/2012CN102844330A Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r)
12/26/2012CN102844048A Pharmaceutical agent for treatment and/or prevention of cancer
12/26/2012CN102839152A High efficient method for obtaining antigen-specific B cells rapidly
12/26/2012CN102838676A Carcino-embryonic antigen monoclonal antibody, chip containing same and application
12/26/2012CN102838675A Ip-10 antibodies and their uses
12/26/2012CN102838674A Method for purifying antibodies using high-density peridium magnetic beads of protein A
12/26/2012CN102838673A Methods of modifying antibodies and modified antibodies with improved functional properties
12/26/2012CN102838659A Plasmodium vivax antigen polypeptide, IgY antibody, and application thereof in malaria diagnosis
12/26/2012CN102838657A Human tumor marker TBRG4 (transforming growth factor beta regulator 4) polypeptide and application thereof
12/26/2012CN102838555A Hapten, artificial antigen, antibody and synthesis of trinal(2,3-dibromopropyl) triallyisocyanurate
12/26/2012CN102836430A Application of blocking antibody T5E3 to reversing of tumor multidrug resistance
12/26/2012CN102242083B 3D protein monoclonal antibody for resisting novel duck hepatitis virus serotype I
12/26/2012CN102161982B Monoclonal antibodies (McAb) against human CXCR3 molecules and application thereof
12/26/2012CN102094035B Expression vector for constructing high-quality bacteriophage antibody library
12/26/2012CN102080067B Method for detecting deoxynivalenol and special reagent kit thereof
12/26/2012CN101575377B Human cytokine as ligand of zalpha receptor and use thereof
12/26/2012CN101495630B Gene involved in immortalization of human cancer cell and use thereof
12/26/2012CN101460520B Hepatocyte growth factor (hgf) binding proteins
12/26/2012CN101455235B Special yolk antibody preparation for fruit fresh-keeping, preparation method and use thereof
12/26/2012CN101407541B Modified allosteric type cyclic citrulline polypeptide, and fusion protein, antibody and reagent kit thereof
12/26/2012CN101210051B Anti-VEGF antibodies
12/26/2012CN101072587B Anti-cd154 antibodies
12/26/2012CN101048425B KID3 and KID3 antibodies that bind thereto
12/25/2012US8338579 Homogeneous analyte detection
12/25/2012US8338577 Methods for quantifying protein leakage from protein based affinity chromatography resins
12/25/2012US8338576 Antibodies specific for DKK-1 and their uses
12/25/2012US8338575 IL-7 fusion proteins
12/25/2012US8338574 FC variants with altered binding to FCRN
12/25/2012US8338573 Crystal structure of CD147 extracellular region and use thereof
12/25/2012US8338572 Kits for biomarker detection and treatment selection
12/25/2012US8338380 Use of the peptide RFMWMR as a therapeutic agent
12/25/2012US8338379 Monoclonal antibody and use thereof
12/25/2012US8338366 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
12/25/2012US8338364 Peptide tyrosinase inhibitors and uses thereof
12/25/2012US8338156 Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same
12/25/2012US8338140 Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
12/25/2012US8338110 determining levels of one or more oxidized apolipoprotien A-I related biomolecules in a bodily sample; atherosclerosis
12/25/2012US8338107 Method for producing polymers having a preselected activity
12/25/2012US8337855 Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same
1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 1494